News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Gets European OK for Blood Pressure Pill


11/28/2011 7:58:12 AM

Novartis AG said Monday the European Commission has approved Rasitrio, a blood pressure treatment that combines three drugs into one pill. The Swiss drugmaker said Rasitrio combines Rasilez, which inhibits an enzyme produced by the kidneys that can narrow blood vessels; amlodipine, which relaxes blood vessel walls; and hydrochlorothiazide, which increases sodium chloride and water excretion. The medicines lower blood pressure by helping blood flow more easily. A statement from Novartis said most people need several medications to control high blood pressure, and simplifying the treatment is a key to improving patient compliance and outcomes.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES